AIM ImmunoTech Inc.
AIM
$9.21
$0.9110.96%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.91% | -61.27% | -101.53% | 68.44% | 53.75% |
| Total Depreciation and Amortization | -9.38% | 1.59% | 3.28% | 5.17% | 0.00% |
| Total Amortization of Deferred Charges | -7.25% | 281.58% | -119.29% | 169.86% | -- |
| Total Other Non-Cash Items | -6.90% | 157.78% | -78.57% | 700.00% | -84.51% |
| Change in Net Operating Assets | -44.17% | 267.53% | 116.96% | -396.34% | -63.21% |
| Cash from Operations | 40.30% | -27.17% | -3.39% | 37.53% | 50.66% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.76% | 952.27% | -57.38% | 622.78% | 41.70% |
| Cash from Investing | -75.76% | 1,008.98% | -59.56% | 622.78% | 26.17% |
| Total Debt Issued | -- | -100.00% | 200.00% | -105.32% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,962.50% | 700.00% | -99.24% | 60.18% | 123.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -36.35% | 656.93% | -94.39% | -13.72% | 1,824.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.16% | 129.78% | -1,118.92% | 112.08% | 78.18% |